Poolbeg Pharma PLC (POLB)

London
Currency in GBP
4.65
+0.05(+1.09%)
Closed
POLB Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
4.474.77
52 wk Range
3.5515.77
Key Statistics
Edit
Bid/Ask
4.60 / 5.10
Prev. Close
4.6
Open
4.54
Day's Range
4.47-4.77
52 wk Range
3.55-15.77
Volume
1.02M
Average Volume (3m)
2.12M
1-Year Change
-49.45%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
POLB Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week
Show more

Poolbeg Pharma Company Profile

Poolbeg Pharma PLC operates as a biopharmaceutical company, engages in the development and commercialization of medicines for unmet medical needs in the United Kingdom. It develops POLB 001, which is in phase 1 clinical study for cancer immunotherapy-induced cytokine release syndrome and severe influenza. The company is also developing oral encapsulated GLP-1R agonist for obesity and diabetes treatment; influenza and respiratory syncytial virus AI programme; POLB 002, an inlicensed firstinclass broad spectrum RNAbased immunotherapy for respiratory virus infections; and POLB 003, an intramuscular vaccine to prevent Melioidosis. In addition, it has a license to encapsulation technology for oral vaccine delivery platform that delivers immune stimulating antigens to various areas of the gut. Further, the company is involved in the development of biomarker platform to identify those at risk of developing severe disease; and vaccine discovery platform, a model-derived discovery platform to identify new vaccine candidates. Poolbeg Pharma plc was incorporated in 2021 and is headquartered in London, the United Kingdom.

Compare POLB to Peers and Sector

Metrics to compare
POLB
Peers
Sector
Relationship
P/E Ratio
−5.3x−2.0x−0.6x
PEG Ratio
−0.51−0.010.00
Price/Book
1.8x2.1x2.6x
Price / LTM Sales
-2.0x3.1x
Upside (Analyst Target)
313.0%71.0%51.5%
Fair Value Upside
Unlock9.8%8.4%Unlock

Earnings

Latest Release
Apr 12, 2023
EPS / Forecast
-0.01 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

18.50
CREO
-2.63%
4.25
VRCI
0.00%
0.05
KATK
0.00%
0.24
CLAI
-8.00%
108.60
AML
+6.47%

FAQ

What Is the Poolbeg Pharma (POLB) Stock Price Today?

The Poolbeg Pharma stock price today is 4.65

What Stock Exchange Does Poolbeg Pharma Trade On?

Poolbeg Pharma is listed and trades on the London stock exchange.

What Is the Stock Symbol for Poolbeg Pharma?

The stock symbol for Poolbeg Pharma is "POLB."

What Is the Poolbeg Pharma Market Cap?

As of today, Poolbeg Pharma market cap is 23.00M.

What is Poolbeg Pharma Earnings Per Share?

The Poolbeg Pharma EPS is -0.009.

From a Technical Analysis Perspective, Is POLB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.